Valuation: Consort Medical plc

Market Cap 502M 433M 407M 370M 696M 47.99B 706M 4.77B 1.87B 24.04B 1.88B 1.84B 79.98B P/E 2018
36.7x
P/E 2019 43.5x
Enterprise Value 599M 517M 485M 442M 831M 57.3B 843M 5.69B 2.23B 28.71B 2.25B 2.2B 95.5B EV / Sales 2018
2.2x
EV / Sales 2019 1.8x
Free-Float
-
Yield 2018
1.75%
Yield 2019 2.32%
Director TitleAgeSince
Director/Board Member 46 2023-01-31
Director/Board Member 52 2024-03-31
Director/Board Member 53 2024-03-31
Date Insider Type Main position Quantity % Market Cap.
2/6/20 Sell 211,474 0.4284%
2/6/20 Fiscal year 211,474 0.4284%
2/6/20 Sell 467 0.0009%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+0.50% - - 628M
-0.80%+1.76%-15.15%+5.34% 193B
-0.34%+1.91%-1.83%+11.72% 117B
+0.02%-3.26%+8.28%+74.67% 59.89B
-0.92%+2.96%+36.26%+64.79% 56.01B
-0.38%+1.74%-6.28%-33.67% 49.96B
-1.45%+0.90%+9.42%-17.97% 33.87B
-2.70%+2.88% - - 31.36B
-1.96%+10.41%-4.73%+24.70% 24.77B
-0.05%-0.68%+43.87%-10.98% 24.59B
Average -0.86%+3.26%+8.73%+14.82% 59.04B
Weighted average by Cap. -0.78%+3.34%+0.65%+15.31%

Financials

2018 2019
Net sales 311M 269M 252M 229M 432M 29.75B 437M 2.95B 1.16B 14.9B 1.17B 1.14B 49.57B 305M 263M 247M 225M 423M 29.17B 429M 2.9B 1.14B 14.61B 1.15B 1.12B 48.62B
Net income 16.1M 13.9M 13.04M 11.88M 22.33M 1.54B 22.64M 153M 59.9M 771M 60.45M 59.14M 2.57B 10.5M 9.06M 8.5M 7.75M 14.56M 1B 14.77M 99.69M 39.07M 503M 39.42M 38.57M 1.67B
Net Debt 95.5M 82.45M 77.35M 70.45M 132M 9.13B 134M 907M 355M 4.57B 359M 351M 15.22B 97.4M 84.09M 78.89M 71.85M 135M 9.31B 137M 925M 362M 4.67B 366M 358M 15.52B
Logo Consort Medical plc
Consort Medical PLC is a United kingdom-based company that operates as a holding company. The Company wit its subsidiaries engaged in contract development and manufacturing organization (CDMO). The Company's services include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica. Bespak's core business is the manufacture of inhaled drug delivery devices for life sciences partners and its operations are based in the United Kingdom. The Aesica business manufactures and sells active pharmaceutical ingredients (API), formulated pharmaceutical products and packaging services to the pharmaceutical industry and its operations are based in the United Kingdom and Europe. It offers its services to customers, such as pharmaceutical companies and life sciences.
Employees
-
  1. Stock Market
  2. Stocks
  3. CSRT Stock